Yves Chrétien

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

Christophe Corpechot, Ludovico Abenavoli, Nabila Rabahi et al. · Hepatology · 2008 · 637 citations

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis

Gabriel Perlemuter, Abdelmajid Sabile, Philippe Lettéron et al. · The FASEB Journal · 2002 · 571 citations

Hepatology, Hepatitis C, Biochemistry +15

IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?

Raoul Poupon, RenéeE. Poupon, Yvon Calmus et al. · The Lancet · 1987 · 538 citations

Hepatology, Biliary Tract, Liver Physiology +9

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis

Christophe Corpechot, Fabrice Carrat, Abbas Bahr et al. · Gastroenterology · 2005 · 388 citations

Urology, Hepatology, Biliary Tract +11

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.

M. Housset, C Maulard, Yves Chrétien et al. · Journal of Clinical Oncology · 1993 · 316 citations